Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to assess efficacy of UK-453,061 when used in combination with tenofovir DF/emtricitabine, as measured by percentage of subjects with HIV-1 RNA <48 copies/mL at 48 weeks.
Critère d'inclusion
- HIV in particular against drug-resistant virus, especially the clinicallysignificant mutants (K103N, Y181C, and L100I)